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ABSTRACT Functional comparison of skeletal muscle (rSkM1) and cardiac (hH1) voltage-gated sodium channel isoforms
expressed in Chinese hamster ovary cells showed rSkM1 half-activation (Va) and inactivation (Vi) voltages 7 and 10 mV more
depolarized than hH1 Va and Vi, respectively. Internal papain perfusion removed fast inactivation from each isoform and
caused a 20-mV hyperpolarizing shift in hH1 Va, with an insignificant change in rSkM1 Va. Activation voltage of the
inactivation-deficient hH1 mutant, hH1Q3, was nearly identical to wild-type hH1 Va, both before and after papain treatment,
with hH1Q3 Va also shifted by nearly 20 mV after internal papain perfusion. These data indicate that while papain removes
both hH1 and rSkM1 inactivation, it has a second effect only on hH1 that causes a shift in activation voltage. Internal treatment
with an antibody directed against the III-IV linker essentially mimicked papain treatment by removing some inactivation from
each isoform and causing a 12-mV shift in hH1 Va, while rSkM1 Va remained constant. This suggests that some channel
segment within, near, or interacting with the III-IV linker is involved in establishing hH1 activation voltage. Together the data
show that rSkM1 and hH1 activation mechanisms are different and are the first to suggest a role for a cytoplasmic structure
in the voltage-dependent activation of cardiac sodium channels.
INTRODUCTION
Voltage-gated sodium channels are responsible for the ini-
tiation and propagation of nerve, skeletal muscle, and car-
diac action potentials. The orchestrated activation and inac-
tivation gating of sodium channels is vital to normal
neuronal signaling, skeletal muscle contraction, and normal
heart rhythms. Voltage-gated sodium channels as well as
many other ion channels are molecularly diverse, with dif-
ferent channel isoforms expressed specifically by cell type
or throughout development (for reviews see Kallen et al.,
1993; Catterall, 1995; Jan and Jan, 1997). Often several
isoforms are expressed within a single cell. To date, at least
nine different sodium channel  subunit isoforms from a
single species have been isolated and cloned. What is the
need for this diversity of channels? What are the functional
differences among these isoforms, and how are these dif-
ferences relevant to the cell type and/or developmental stage
in which the channel is expressed?
These questions as well as basic questions relating chan-
nel structure to function can be addressed through stable and
transient expression of ion channels in mammalian and
amphibian heterologous expression systems. Comparison of
mutant versus wild-type channel function expressed in het-
erologous systems has provided significant insight into the
functionally relevant regions of ion channels (see, e.g.,
Stuhmer et al., 1989; Ukomadu et al., 1992; West et al.,
1992). In addition, functional differences among isoforms
of a given ion channel species can be observed through
parallel experimentation in a single cellular system.
Previous reports compared function of the skeletal mus-
cle sodium channel isoforms SkM1 and SkM2 (H1) tran-
siently expressed in Xenopus oocytes and in a human em-
bryonic kidney (HEK)-derived cell line, tsA201 (Chen et
al., 1992; Chahine et al., 1996; Wang et al., 1996; Rich-
mond et al., 1998). These two isoforms are expressed na-
tively in adult (SkM1) and embryonic (SkM2; also dener-
vated) skeletal muscle, respectively (Trimmer et al., 1990;
Yang et al., 1991; Gellens et al., 1992; Kallen et al., 1993).
The H1 isoform is the predominant channel isoform ex-
pressed in the heart and is identical to SkM2 (Rogart et al.,
1990; Gellens et al., 1992).
Here functional comparison of rSkM1 and hH1 in a
Chinese hamster ovary (CHO) cell line, CHO-K1, reveals a
novel difference in function between the two isoforms.
While internal papain treatment removes both rSkM1 and
hH1 inactivation, the half-activation voltage (Va) for hH1 is
also shifted dramatically in the hyperpolarized direction
with little or no impact on rSkM1 Va. The data are consistent
with a major difference between hH1 and rSkM1 in their
voltage dependence of activation, indicating that hH1 acti-
vation can be altered through cytoplasmic channel struc-
tures. The possibility that the kinetic uncoupling of inacti-
vation from activation is responsible for this shift in Va is
ruled out through studies of the inactivation-deficient mu-
tant hH1Q3, in which hH1Q3 Va closely follows hH1 Va. In
the mutant, hH1Q3, the IFM consensus inactivation se-
quence (a.a. 1484–1486) was replaced with three glutamine
residues to remove fast inactivation (see Hartmann et al.,
1994). This is investigated further by comparing hH1 and
rSkM1 function before and after treatment with an affinity-
purified antibody directed against the putative inactivation
loop (III-IV linker). These data are similar to those observed
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after papain treatment, indicating some type of interaction
between the heart channel isoform III-IV linker (but not the
IFM consensus inactivation sequence directly) and the ac-
tivation mechanism. Because rSkM1 activation is not al-
tered by such treatment, rSkM1 is missing this sequence or
it is differently linked to channel activation. These data
imply that cytoplasmic structural differences between car-
diac and skeletal muscle sodium channel isoforms exist that
have direct and different impacts on channel activation, and
they are the first examples to indicate that cytoplasmic
structures affect voltage-dependent cardiac channel activation.
MATERIALS AND METHODS
CHO cell transfection and tissue culture methods
CHO cells were transfected with the plasmid rSkM1-pZem (Bennett et al.,
1997; rSkM1 first isolated and cloned by Trimmer et al., 1989) or hH1-
CMV (a generous gift of R. G. Kallen; first isolated and cloned by Gellens
et al., 1992) via a calcium phosphate-mediated technique using 20 g DNA
and 5  105 cells in 10 ml of Dulbecco’s minimum essential medium-fetal
bovine serum as described previously (Bennett et al., 1997). After 24 h of
incubation with DNA, standard culturing conditions were resumed. After 3
days, stably transfected cells were selected with 500 g/ml Geneticin
(G418; GIBCO). Transfected cells were grown to confluence (3 weeks)
and then passaged.
The experiments shown in Fig. 7 compare the function of hH1 and that
of the inactivation-deficient mutant, hH1Q3 (a generous gift of Dr. H.
Hartmann). In the mutant hH1Q3, the IFM consensus inactivation se-
quence (a.a. 1484–1486) was replaced with three glutamine residues (see
Hartmann et al., 1994). hH1 and hH1Q3 expression vectors were trans-
fected into CHO cells by liposomal technologies. Briefly, CHO cells were
passaged onto 35-mm culture plates at 40% confluence. After a 24-h
incubation, cells were then exposed to a 1-ml Opti-MEM (GIBCO Life
Technologies) medium containing 8 l lipofectamine (GIBCO) and 1–2
g DNA, consisting of 12% pGreen Lantern-1 (GFP; GIBCO) and
88% either hH1 or hH1Q3 expression vector. After a 5-h incubation at
37°C in a 5% CO2 humidified incubator, the medium was exchanged for
normal, nonselective CHO cell growing medium. Cells were incubated for
60–72 h before electrophysiological recordings, selecting cells expressing
GFP.
Controls were conducted to ensure that channel function in transient
transfectants was not different from channel activity in stably transfected
CHO cells. Transient transfectants showed typical activation voltages,
reversal potentials, current levels, kinetics, etc., indicating no significant
difference in channel function between stable and transient transfectants.
For example, transient hH1 Va measured 30.4  2.9 mV (n  3), while
stable hH1 Va was 28.6  1.8 mV (n  7). In addition, as shown in Fig.
1 below for the stable transfectants, neither hH1 nor hH1Q3 transient
transfectants showed any drift in voltage-dependent gating over time (n 
5 for each channel type).
Antibody production and purification
Site-directed polyclonal antibodies (1Abs) were raised to an 18-mer
peptide (pep-1;  Diagnostics) corresponding to the highly conserved
III-IV linker region (TEEQKKYYNAMKKLGSKK) in vertebrate sodium
channels and were affinity-purified on a pep-1-coupled column. Antibody
concentrations were assayed using optical density (O.D.) measurements at
a 280-nm wavelength, with the accepted estimate that a 1.0 O.D. reading
approximates 0.8 mg/ml 1Ab (Harlow and Lane, 1988).
Whole-cell recording of sodium currents in
CHO cells
CHO cells were studied using the patch-clamp whole-cell recording tech-
nique described previously (Bennett et al., 1997). Cells were passaged and
plated on 35-mm culture dishes 24–96 h before the experiment.
An Axon Instruments 200B patch-clamp amplifier with a CV203BU
headstage (Axon Instruments) was used in combination with a Nikon
TE300 inverted microscope. Pulse protocols were generated using a 200-
MHz Pentium II computer (Dell Computers) running Pulse acquisition
software (HEKA). The resultant analog signals were filtered at 5 kHz (50
kHz for the kinetic studies), using an eight-pole Bessel filter (9200 LPF;
Frequency Devices) and then digitized using the ITC-16 AD/DA converter
(Instrutech).
Narishige micromanipulators (both mechanical and hydraulic) were
used to place the electrode on the cell. Electrode glass (Drummond capil-
lary tubes, 2-000-210) was pulled using a two-step process on a Sutter
(model P-87) electrode puller to a resistance of 1–2 M measured in the
salt solutions used. Two different sets of solutions were used, solution set
A (Fig. 1, A–C) and solution set B (Figs. 1 D through 9). External solution
A was (in mM) 134 NaCl, 4 KCl, 1.5 CaCl2, 1.5 MgCl2, 5 glucose, and 5
HEPES, and internal solution A was (in mM) 90 CsF, 60 CsCl, 11 NaCl,
and 5 HEPES. (Both solutions were titrated with 1 N NaOH to pH 7.4 at
room temperature.) External solution B was (in mM) 224 sucrose, 22.5
NaCl, 4 KCl, 2.0 CaCl2, 5 glucose, and 5 HEPES, and internal solution B
was (in mM) 120 sucrose, 60 CsF, 32.5 NaCl, and 5 HEPES (titrated with
1 N NaOH to pH 7.4 at room temperature). Please note the low ionic
strength of solution set B. Currents measured using these solutions are
approximately one-fourth the magnitude of currents measured using set A
solutions. Although series resistance was compensated 95–98% for all
data, the smaller current produced using set B solutions further minimized
any remaining series resistance error. All solutions were filtered using
Gelman 0.2-m filters immediately before use. All experiments were
carried out at room temperature (21–23°C).
Pulse protocols
Conductance-voltage (G-V) relationship
The cell was held at 100 mV, stepped to various depolarized potentials
(ranging from60 (or80) to	100 mV in 10-mV increments) for 10 ms,
and then returned to the holding potential. Consecutive pulses were stepped
every 1.5 s, and the data were leak subtracted using the P/4 method,
stepped negatively from the 100 mV holding potential. At each test
potential, steady-state whole-cell conductance was determined by measur-
ing the peak current at that potential and dividing by the driving force (i.e.,
difference between the membrane potential and the observed reversal
potential). The maximum conductance generated by each cell was used to
normalize the data for each cell to its maximum conductance by fitting the
data to a single Boltzmann distribution (Eq. 1). The average Va  SEM
values listed throughout are determined from these single Boltzmann
distributions. The normalized data were then averaged with those from
other cells, and the resultant average conductance-voltage curve was fit via
least squares, using the following Boltzmann relation:
Fraction of maximal conductance
 
1 exp V Va/Ka)]1,
(1)
where V is the membrane potential, Va is the voltage of half-activation, and
Ka is the slope factor.
Steady-state inactivation curves (hinf)
The voltage dependence of steady-state inactivation was determined by
first prepulsing the membrane for 500 ms from the 100 mV holding
potential, then stepping to 	60 mV for 5 ms, and then returning to the
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100-mV holding potential. The prepulse voltages ranged from130 mV
to 	10 mV in 10-mV increments. The currents from each cell were
normalized to the maximum current. The normalized data for many cells
were then averaged and fit to Eq. 2, from which the mean Vi and slope
factor (Ki) parameters describing steady-state inactivation for the channel
population were calculated:
Fraction of maximum current 
1 expV Vi/Ki)]1.
(2)
Recovery from inactivation
Cells were held at 100 mV, then stepped to 	60 mV for 10 ms and
returned to the recovery potential for a varying duration ranging from 1 to
20 ms in 1-ms increments. After this recovery pulse, the potential was
again stepped to 	60 mV for 10 ms. The peak currents measured during
the two 	60-mV depolarizations were compared, and the fractional peak
current remaining during the second depolarization was plotted as a func-
tion of the recovery pulse duration. This represents the percentage of
channels that recovered from inactivation during the recovery interval.
Time constants of recovery were determined by fitting the data to single-
exponential functions.
Measurement of gating kinetics
Sodium channel inactivation was removed to measure directly the time
constants of channel activation and deactivation. Before inactivation re-
moval, normal current traces were obtained for later extraction of inacti-
vation time constants. Cells were internally perfused with papain (1 mg/ml
Type X; Sigma) as described (Bennett et al., 1997); removal of inactivation
occurred within 15 min.
To determine deactivation time constants, channels were fully activated
after papain treatment with a pulse to	60 mV for 1.0 ms, and deactivation
currents were elicited by hyperpolarizing pulses from 80 to 30 mV
(50 mV for hH1) for 10 ms. Deactivation time constants were obtained
by fitting the resultant currents to a single-exponential decay.
Activation time constants were calculated for potentials ranging from
60 mV (50 mV for rSkM1) to 	20 mV, using the standard activation
protocol (above) and fitting the rise of current (in the absence of inactiva-
tion) to the steady state, using a fourth-power exponential function (Ox-
ford, 1981) as follows:
y y01 exp(t/m))4, (3)
where y0 is the peak current at the test potential, t is the time after the pulse
onset, and m is the activation time constant. Fits of the data using
exponential functions raised to various powers indicated that the fourth-
power exponential fit the data best.
Inactivation time constants were determined by fitting the current traces
obtained from the same cell before removal of inactivation. Attenuating
currents from 90% to 10% of the peak values were fit to a single-
exponential function. All currents were analog filtered at 50 kHz before
digitization to improve time resolution.
Internal perfusion of 1Ab and pep-1
The purified antibody, 1Ab, was added to internal solution B to a final
concentration of 80 g/ml. The blocking peptide, pep-1, was added to this
solution at a concentration of 80 g/ml.
Data analysis
The data were analyzed using a combination of Pulse/PulseFit (HEKA) and
SigmaPlot 4.0 (Jandel Scientific) software.
RESULTS
rSkM1 and hH1 activation voltages are stable as
expressed in CHO cells
Whole-cell currents were recorded from CHO-K1 cells
transfected with rSkM1 (CHOM1) and hH1 (CHOH1).
Peak sodium currents of 0.5–8 nA were recorded in most
transfected cells and showed rapid activation and inactiva-
tion, reversing at potentials consistent with those predicted
by the Na	 concentration gradients. Current traces with
similar characteristics were observed using either solution
set A or solution set B. Peak currents measured in set A
solutions were about four times those measured in set B
solutions, consistent with the predicted impact of the low-
ered ionic strength of set B solutions. There was no detect-
able decrease in sodium channel expression with subsequent
passaging, indicating stable expression of rSkM1 and hH1
in CHO cells.
Throughout this study, data were collected at times from
5 to 30 min after attainment of the whole-cell configuration
(WCR). Most experiments were completed within 15–20
min. Previous reports studying sodium channel function in
tsA201 cells indicated that the voltage of activation drifted
in the hyperpolarizing direction over time (Chahine et al.,
1996; Wang et al., 1996). Wang et al. (1996) showed that
the voltage of half-activation (Va) for hSkM1 shifted by
25 mV in the hyperpolarized direction within 60 min after
WCR, while hH1 showed a smaller shift that stabilized
within 20 min.
FIGURE 1 There is no time-dependent shift in activation voltage. (A)
CHOM1 current trace during a 10 mV test potential at 5 (——) and 14
(E) min after WCR. (B) CHOH1 current trace during a 0-mV test potential
at 5 (——) and 16 () min after WCR. (C) Current-voltage (I-V) rela-
tionship for a CHOM1 cell measured at two times after WCR. Points are
peak currents measured at 5 (E) and 33 (F) min after WCR. (D) I-V
relationship for a CHOH1 cell measured at two times after WCR. Points
are peak currents measured at 5 () and 25 (f) min after WCR.
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There is no sign of such a drift in voltage dependence
over time (starting 5 min post-WCR) for rSkM1 or for hH1
as expressed in CHO cells. Fig. 1 shows typical current
traces for a CHOM1 (Fig. 1 A) and a CHOH1 (Fig. 1 B) cell
at 5 and 15 min after WCR. Note that there is no differ-
ence between the current traces over time. Furthermore, Fig.
1 shows the current-voltage relationships for another
CHOM1 (Fig. 1 C) and a CHOH1 (Fig. 1 D) cell at 5 and
25–33 min after WCR. Note that neither rSkM1 nor hH1
shows any significant drift in voltage dependence with time.
These experiments were repeated many times in both solu-
tion sets and for hH1 and hH1Q3 transient transfectants,
with no indication of any significant drift in activation
voltage over time (n  25). Thus, for the time course of
experiments used throughout this study, there is no drift in
gating voltage dependence.
rSkM1 versus hH1: comparison of
steady-state parameters
Fig. 2 A shows the conductance-voltage curve comparing
rSkM1 and hH1 steady-state activation as expressed in
CHO cells. hH1 activates at potentials 7 mV more hyper-
polarized than does rSkM1, with Va   21.8  2.6 mV
(n  8) and  28.6  1.8 mV (n  7) for rSkM1 and hH1,
respectively.
Fig. 2 B shows the hinf curve for rSkM1 versus hH1 and
indicates that hH1 inactivates at potentials 10 mV more
hyperpolarized than rSkM1, with Vi  59.4  3.2 mV
(n  10) and 69.4  2.9 mV (n  7) for rSkM1 and hH1,
respectively.
Recovery from inactivation: rSKM1 recovers
more quickly than hH1
Fig. 3 A shows the rate of recovery from inactivation for
each isoform. Note that rSkM1 recovers from inactivation
more rapidly than hH1. At a 120-mV recovery potential,
the recovery time constant () was 1.1  0.1 ms (n  7) for
rSkM1 and  was 2.1  0.1 ms (n  5) for hH1. Recovery
from inactivation was complete in these cells, with no
indication of a second, slower rate to recovery.
Fig. 3 B plots the potential dependence of the recovery
rates and shows that the two isoforms, while recovering
from inactivation with inherently different rates, show sim-
ilar potential dependencies. These data indicate that that the
absolute rate of recovery from inactivation distinguishes the
isoforms and not the relative potential dependence of the
recovery mechanism. Recovery time constants increased
e-fold every 24 and 29 mV for hH1 and rSkM1, respec-
tively. These values are in close agreement with previous
reports for other sodium channel isoforms (Keynes, 1986;
Patlak, 1991).
Gating kinetics for rSkM1 versus hH1
Fig. 4 A plots the time constants of activation and deacti-
vation for rSkM1 versus hH1 and shows that hH1, at the
activating potentials ranging from 50 to 	20 mV, acti-
vates more rapidly than rSkM1, consistent with the relative
potential dependence of steady-state activation (see the G-V
curves of Fig. 5, C and D, following papain treatment).
Fig. 4 B shows the time constants of inactivation and
indicates that hH1 inactivates slightly faster than rSkM1 at
small depolarizations. The rates of inactivation for the two
isoforms converge at larger depolarizations. The percentage
of a second, slower inactivation rate, calculated by fitting
the offset of current to a double-exponential function, was
minimal for each isoform, with hH1 showing an average
7.1 1.2% (n 30) slower inactivation versus 7.7 1.1%
(n  61) for rSkM1.
FIGURE 2 Comparison of rSkM1 and hH1 steady-state gating parame-
ters. (A) Conductance-voltage (G-V) relationship. Data are the average
normalized peak conductance  SEM at a membrane potential. Curves are
fits of the data to single Boltzmann distributions. E, rSkM1; , hH1.
Average voltages of activation (Va)  21.8  2.6 mV (rSkM1; n  8);
28.6*  1.8 mV (hH1; n  7). Significance was tested throughout using
a two-tailed test, demarcating significance as follows: *, p  0.05; **, p 
0.01; #, not significant (p  0.05). (B) Steady-state inactivation (hinf). Data
are the average normalized current  SEM measured during a 5-ms pulse
to	60 mV after a 500-ms prepulse to the plotted potentials. Curves are fits
of the data to single Boltzmann distributions. E, rSkM1;, hH1. Average
voltages of half-inactivation (Vi)  59.4  3.2 mV (rSkM1; n  10);
69.4*  2.9 mV (hH1; n  7).
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Internal papain removes inactivation from rSkM1
and from hH1—a large shift in hH1 activation
voltage is also observed, with little effect on
rSkM1 Va
To determine accurately the rates of activation and inacti-
vation, the gating processes must be separated. As such,
sodium channel inactivation was removed through internal
papain perfusion, and the gating time constants shown in
Fig. 4 were measured. Fig. 5, A and B, shows current traces
from CHOM1 and CHOH1 cells before and after complete
removal of inactivation, respectively. Whole-cell currents
were smaller after papain treatment, with relative peak
conductances of 71.9  10.0% (n  8) and 71.1  8.8%
(n  7) of control peak conductance for rSkM1 and hH1,
respectively.
A notable difference in channel gating between the two
isoforms was observed after papain treatment. Fig. 5 shows
the average G-V relationships for rSkM1 (Fig. 5 C) and hH1
(Fig. 5 D) before and after removal of inactivation. Note
that rSkM1 Va is only slightly (insignificantly) affected by
papain treatment, while hH1 Va shifts by more than 20 mV
in the hyperpolarized direction after papain treatment. This
phenomenon was observed for all CHOH1 cells tested, with
hyperpolarizing shifts in Va ranging from 13 to 29 mV,
averaging 20.7  1.9 mV (n  7).
The time to peak current for hH1 does not
change when inactivation is removed
Previous reports have described channel activity after the
removal of inactivation through enzyme treatment and/or
chemical modification (Armstrong and Bezanilla, 1973,
1977; Eaton et al., 1978; Oxford et al., 1978; Horn et al.,
FIGURE 3 Recovery from inactivation is relatively rapid for both iso-
forms. (A) Recovery from inactivation at a 120 mV recovery potential.
Data represent the average fractional current measured as described, after
a 120 mV recovery potential of varied duration. Curves are fits of the
data to single exponential functions. E, rSkM1; , hH1. Time constants
(): rSkM1  1.1  0.06 ms (n  7); hH1  2.1**  0.1 ms (n  5). (B)
Potential dependence of recovery time. Data are the time constants of
recovery, measured as in A at different recovery potentials (E, rSkM1; ,
hH1; n  5–7 for each point). Curves are fits of the data to a single
exponential function and indicate an e-fold increase in hH1 and rSkM1
every 24-mV and 29-mV depolarization, respectively.
FIGURE 4 Comparison of rSkM1 and hH1 activation and inactivation
rates. (A) Time constants of activation and of deactivation. Data are the
average time constants  SEM after the removal of inactivation and
determined as described in Materials and Methods. Curves are nontheo-
retical point to point. F, rSkM1 activation (n  5); E, rSkM1 deactivation
(n 5); f, hH1 activation (n 4);, hH1 deactivation (n 4). (B) Time
constants of inactivation. Data are the average time constants of inactiva-
tion  SEM measured as described in Materials and Methods. Curves are
nontheoretical, point to point. E, rSkM1 (n  7); , hH1 (n  7).
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1980; Oxford, 1981; Stimers et al., 1985; Gonoi and Hille,
1987; Kirsch et al., 1989). In most tissues, investigators
have found results similar to those observed here for rSkM1.
That is, removal of fast inactivation, regardless of the
method, had a measurable impact on only two aspects of
channel function: inactivation was removed in all cases, and
the current magnitude may have been reduced. The voltage
dependence of activation was essentially unaltered.
One set of notable exceptions to these findings was
shown for sodium channel function in neuroblastoma cell
lines (Gonoi and Hille, 1987; Kirsch et al., 1989). Gonoi
and Hille reported a 25-mV hyperpolarizing shift in Va after
removal of inactivation with several different chemical
modifiers. The authors concluded that activation voltages
shift because of the uncoupling of fast inactivation from
slow activation at small depolarizations. When inactivation
is removed, the channels, while activating at lesser depo-
larizations, do so relatively slowly because the effect of a
relatively fast inactivation is unmasked. That is, at small
depolarizations, Na	 channel activation in neuroblastoma
cells is essentially rate-limiting, indicated by the current
reaching peak amplitude at later times after the removal of
inactivation (see the Discussion for details).
Fig. 6 shows current traces for a CHOH1 cell at four
depolarizations ranging from 60 to 30 mV in the pres-
ence and absence of inactivation. Peak currents at each
potential are normalized so that peak times can be compared
more directly. Note that at all four voltages, currents in the
presence and absence of inactivation peak at nearly identical
times, indicating that hH1 activation at these small depo-
larizations is not rate limiting. Similar results were observed
many times and were repeated for CHOM1 cells (data not
shown), with no change in the time at which the current
peaked after the removal of inactivation.
Removal of fast inactivation through mutation
has no effect on hH1 activation voltage: papain
treatment of hH1Q3 produces a shift in Va similar
to the papain-treated hH1 shift
If rate-limiting activation at small depolarizations were re-
sponsible for the measured shift in Va after the removal of
inactivation, then one would predict that any means by
which inactivation is removed should cause a shift in Va. As
such, the mutant hH1Q3 (replacing the IFM consensus
FIGURE 5 Papain removes rSkM1 and hH1 inactivation but causes a shift only in hH1 activation voltage. (A) Whole-cell current trace from a typical
CHOM1 cell to a 	30-mV test potential before and after the removal of inactivation through internal papain treatment. (B) Whole-cell current trace from
a typical CHOH1 cell to a 	30-mV test potential before and after the removal of inactivation through internal papain treatment. (C) G-V relationship for
rSkM1 before and after papain treatment. Data are the average normalized peak conductance  SEM at a membrane potential. Curves are fits of the data
to single Boltzmann relationships. E, Inactivation present; Va  21.8  2.6 mV. F, Inactivation removed; Va  26.8#  2.2 mV. n  8 for each set.
(D) G-V relationship for hH1 before and after papain treatment. Data are the average normalized peak conductance SEM at a membrane potential. Curves
are fits of the data to single Boltzmann relationships. , Inactivation present; Va  28.6  1.8 mV. f, Inactivation removed; Va  49.3**  2.5 mV.
n  7 for each set.
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inactivation sequence with three glutamine residues to re-
move fast inactivation; see Hartmann et al., 1994) was
transfected into CHO cells, producing essentially noninac-
tivating currents, as shown in Fig. 7 A. Fig. 7 B shows the
G-V curve comparing hH1 and hH1Q3, with no significant
differences in the voltage dependence of channel activation.
Interestingly, as shown in Fig. 7 C, when hH1Q3 is
treated with papain, hH1Q3 Va shifts by nearly 20 mV. This
is very similar to the shift in hH1 Va measured after papain
treatment. Thus, as shown in Fig. 7 B and C, hH1Q3 Va
follows hH1 Va very closely, both before and after papain
treatment. Together, these data directly indicate that the
shift in hH1 Va is not due to the uncoupling of inactivation
from activation, but that papain must impose a second,
independent effect on hH1 and on hH1Q3.
The III-IV linker may be involved in the shift in
hH1 gating
The data shown in Figs. 6 and 7 above indicate that papain
has a second, independent effect on hH1 and hH1Q3 activ-
ity. In addition to removing inactivation through the appar-
ent clipping of the III-IV linker, it is quite possible that
papain also cuts a second loop in hH1 and in hH1Q3 that
imposes some structural (or perhaps electrostatic) effect on
hH1 activation voltage that is unrelated to inactivation or to
the III-IV linker. From the described papain experiments,
one can conclude only that some cytoplasmic region of hH1
(hH1Q3) is affected differently than rSkM1 during papain
treatment, resulting in a hyperpolarizing shift in hH1 and in
hH1Q3 Va with little or no effect on rSkM1 Va.
Previously, treatment of rat brain IIA sodium channel
with an antibody directed against the conserved III-IV
linker region caused a fraction of fast inactivation to be
removed (Vassilev et al., 1988, 1989). As such, an affinity-
purified antibody directed against the III-IV region was
produced and developed (1Ab; see Materials and Meth-
ods). 1Ab was added to the recording pipette solution to
determine whether the III-IV linker region is also responsi-
ble for the shift in hH1 Va.
Fig. 8, A and B, gives examples of rSkM1 and hH1
whole-cell currents, respectively, before and after 1Ab
FIGURE 6 Time to peak hH1 current does not change with papain
treatment. Whole CHOH1 cell current measured in the presence and
absence of inactivation after papain treatment at four small depolarizations.
Peak currents at each potential were normalized for comparison. The
scaling factor used to normalize is shown beside the adjusted trace. Note
that the time at which the currents peak does not change after the removal
of inactivation.
FIGURE 7 Activation voltage of the inactivation-deficient mutant,
hH1Q3, closely follows hH1 Va before and after papain treatment. (A)
Typical whole-cell Na	 current traces from a cell expressing hH1Q3.
Currents are measured after a step from the 100 mV holding potential to
10-ms test pulses ranging from 60 through 	60 mV in 10-mV steps. (B)
G-V relationship for hH1 versus hH1Q3. Data are the average normalized
peak conductance  SEM at a membrane potential for hH1 (with inacti-
vation intact) versus hH1Q3. Curves are fits of the data to single Boltz-
mann distributions. , hH1; Va  28.6  1.8 mV (n  7). ‚, hH1Q3;
Va  30.8#  2.3 mV (n  4). (C) G-V relationship for hH1Q3 before
and after papain treatment. Data are the average normalized peak conduc-
tance  SEM at a membrane potential. Curves are fits of the data to single
Boltzmann relationships. ‚, Before papain treatment; Va  30.8  2.3
mV. Œ, After papain treatment; Va  49.6**  3.1 mV. n  4 for each
set.
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treatment. For rSkM1, an average 62.8  9.1% of inacti-
vation is removed through 1Ab treatment, ranging from
43% to 82% (n  3). For hH1, antibody treatment removes
an average 45.9  4.9% of inactivation, ranging from 20%
to 60% (n  7). Fig. 8, C and D, shows the average G-V
curves for rSkM1 and hH1, respectively, before and after a
15–30-min exposure to 1Ab. As indicated in Fig. 8 C,
perfusion of 1Ab in CHOM1 has no effect on rSkM1 Va,
consistent with the papain effects on rSkM1 function. How-
ever, as shown in Fig. 8 D, hH1 Va is shifted by 12 mV
with antibody treatment, with the G-V relationship for each
cell shifted in the hyperpolarized direction.
The antibody effect is epitope-specific
To demonstrate that the effect(s) of 1Ab on hH1 gating is
epitope-specific (and not due to some nonspecific effect of
the antibody), 1Ab and the peptide (pep-1) against which
it was made were added together in the intracellular solu-
tion. If the effect of 1Ab is epitope-specific, then pep-1,
when added in sufficient amounts, should bind to 1Ab and
block the 1Ab effect on channel function. Four cells were
tested with the intracellular solution containing both 1Ab
and pep-1, as described in Materials and Methods. The
data indicate that 1Ab was effectively blocked by pep-1
in three of the four cells. That is, current from three of the
four cells retained virtually complete inactivation (90%),
indicating that pep-1 blocked the effect of 1Ab. Fig. 9 A
shows whole-cell current for a typical CHOH1 cell before
and after 1Ab 	 pep-1 treatment. Note that pep-1
protects the channel from any significant removal of inac-
tivation by 1Ab.
Fig. 9 B shows the average G-V curves for hH1 before
and after a 30–40-min perfusion with 1Ab 	 pep-1 for
the three protected cells. Note that pep-1, while limiting
FIGURE 8 rSkM1 and hH1 inactivation are partially removed through internal perfusion of 1Ab, but only hH1 Va is shifted. (A) Whole-cell current
traces from a typical CHOM1 cell to a 	30-mV test potential before and after partial removal of inactivation through internal 1Ab treatment. (B)
Whole-cell current trace from a typical CHOH1 cell to a 30-mV test potential before and after partial removal of inactivation through internal 1Ab
treatment. (C) G-V relationship for rSkM1 before and after 1Ab treatment. Data are the average normalized peak conductance  SEM at a membrane
potential. Curves are fits of the data to single Boltzmann relationships. E, Inactivation present, Va  28.3  1.1 mV. F, 1Ab treated (averaging 63%
inactivation removed), Va  29.3#  1.1 mV. n  3 for each set. (D) Comparison of G-V relationships for hH1 before and after removal of inactivation
through papain and 1Ab treatments. Data are the average normalized peak conductance  SEM at a membrane potential. Nonsolid curves are fits of the
data to single Boltzmann relationships. The solid curve represents a fit of the 1Ab-treated hH1 data to a double Boltzmann relationship, fitting 43.7% at
28.74 mV and 56.3% at 52.49 mV., Inactivation present; Va  30.2  2.3 mV. f, Inactivation removed through papain treatment; Va  49.3 
2.5 mV (see Fig. 5 D). å, 1Ab treated (averaging 46% inactivation removed), Va  41.9**  1.5 mV (significance tested against the “inactivation
present” data). n  7 for each set.
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the removal of inactivation, also prevents the shift in hH1 Va
caused by 1Ab.
For the cell that was not fully protected by pep-1, 45%
of inactivation was removed. In addition, Va for this cell
shifted by 11 mV, similar to the data shown in Fig. 8 D for
antibody-treated cells. This is consistent, for this lone cell,
with pep-1 effectively not blocking the impact of 1Ab on
hH1. For the three protected cells, the data indicate that the
effect(s) of 1Ab on hH1 are epitope-specific and thus
likely involve regions within or intimate with the III-IV
linker.
DISCUSSION
Through direct comparison of the adult skeletal muscle
(rSkM1) versus cardiac and embryonic skeletal muscle
(hH1) sodium channel isoforms, one can begin to charac-
terize differences in sodium channel activity expressed dur-
ing distinct developmental stages and in various adult non-
neuronal excitable tissues. rSkM1 and hH1 were expressed
in CHO cells, and steady-state and kinetic voltage-depen-
dent gating behaviors were compared. In general, rSkM1
gates at more depolarized potentials than hH1, with Va 7 mV
and Vi 10 mV more depolarized for rSkM1 than for hH1.
Consistent with the relative potential dependence of the
steady-state parameters, hH1 gates more rapidly than
rSkM1 at most tested potentials. Furthermore, rSkM1 re-
covers from inactivation faster than hH1 (a 1-ms versus
2-ms time constant at a120-mV recovery potential), while
the potential dependencies of recovery for the two isoforms
were similar.
Thus some basic but relatively subtle differences between
rSkM1 and hH1 function as expressed in CHO cells are
observed. Some of these functional differences between
isoforms are distinct from those previously reported for
rSkM1 and hH1 function as transiently expressed in tsA201
cells (Chahine et al., 1996). These include smaller differ-
ences in Va and Vi, and in inactivation rates. This probably
indicates a functional impact of the cellular system on
channel activity and serves as a reminder of the limitations
of heterologous expression systems. However, because
whole-cell recordings of sodium channels expressed in
CHO cells show no indication of a time-dependent shift in
Va, CHO cells provide a good cellular system for studying
sodium channel activity, particularly voltage- and time-
dependent mechanisms.
Together, the more rapid activation and inactivation ki-
netics and the slower times to recovery from inactivation for
hH1 compared with rSkM1 are consistent with hH1 de-
signed for more rapid progress into the active and inactive
states, while rSkM1 will tend to spend more time in the
closed state.
Internal treatment with papain or with 1Ab
causes a hyperpolarizing shift in hH1 Va but not
rSkM1 Va
Cytoplasmic treatment with a protease or with a site-di-
rected antibody revealed a significant functional difference
between rSkM1 and hH1. As shown in Fig. 5, hH1 Va shifts
significantly after papain treatment, while rSkM1 Va is
insignificantly altered. Treatment with an affinity-purified
antibody directed against the conserved III-IV linker region,
1Ab, partially removed inactivation of both hH1 and
rSkM1 (removing an average 46% and 63% inactivation,
respectively). Only hH1 Va was affected, shifting by 12
mV after a 20–30-min antibody treatment, with an insig-
nificant 1-mV effect on rSkM1 Va. Furthermore, the effect
of 1Ab was shown to be epitope-specific, as illustrated in
Fig. 9, with the effect of 1Ab blocked through coperfusion
of pep-1. Together, the data reveal a significant difference
between hH1 and rSkM1 activation mechanisms.
FIGURE 9 The effect of 1Ab on hH1 Va is epitope-specific. (A) Typ-
ical CHOH1 current traces elicited during a	50-mV test potential at 5 and
36 min after WCR. The cell was perfused with 80 g/ml 1Ab and 80
g/ml pep-1. (B) G-V relationship for hH1 treated with blocked 1Ab.
Data are the average normalized conductances  SEM measured at 5 min
() and 30–35 min (ƒ) after WCR (n  3). Curves are fits of the data to
single Boltzmann relationships.
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What causes a shift in hH1 activation voltage but
not in rSkM1 activation voltage?
Is the shift in hH1 Va coupled to the removal of inactivation,
or is the shift caused by some other phenomenon, such as a
time-dependent shift in Va or a second, independent effect of
papain and 1Ab on hH1 activation voltage? Fig. 1 directly
demonstrates that neither hH1 nor rSkM1 activation volt-
ages “drift” over time, and thus a time-dependent shift in Va
cannot explain the 20-mV shift in hH1 Va that was measured
after the removal of inactivation (over time). Second, care
was taken to ensure that all data measured were corrected
for series resistance (95–98%). To limit further the impact
of any series resistance error, experiments were done using
set B solutions as described in Materials and Methods.
These solutions produce lower currents, further minimizing
any residual series resistance effect on voltage. Thus the
impact of series resistance on the measured Va is minimal
(1 mV) and cannot account for a 20-mV shift in Va.
The kinetic uncoupling of inactivation from slow
activation cannot account for the shift in hH1
activation voltage
As described in the Results, Gonoi and Hille (1987) ele-
gantly showed that a 25-mV shift in neuroblastoma sodium
channel Va was due to the uncoupling of fast inactivation
from a slow activation at small depolarizations. The follow-
ing discussion illustrates that activity of hH1 in CHO cells
cannot be explained by the neuroblastoma model, suggest-
ing that the shifts in hH1 Va caused by papain and 1Ab
treatments are not due to a kinetic uncoupling of inactiva-
tion from activation. The predictions of the neuroblastoma
model are presented, followed by an explanation of how the
data do not support the predictions:
1. The neuroblastoma model predicts that currents at
small depolarizations will reach peak magnitude at a later
time after the removal of inactivation. When inactivation is
present, the current at small depolarizations will reach peak
magnitude more quickly because of the coincidence of slow
activation with fast inactivation. The percentage of channels
in the inactive state at the time of peak current will be
greater at smaller depolarizations, decreasing with depolar-
ization because of the increase in activation rates with
depolarization. The resulting change in the relative distri-
bution of channels among states with depolarization results
in a measured shift in Va (see Hille, 1992, for details). When
inactivation is removed, activation can continue unimpeded
by inactivation, and the current will reach its true peak
value, albeit at a later time. As illustrated in Figs. 6 and 8 B,
there is no change in the time at which hH1 currents peak at
any potential after the removal of inactivation.
2. The neuroblastoma model predicts that Va is artificially
depolarized in the presence of inactivation. Removing in-
activation through any means should unmask this depolar-
izing shift, resulting in the measurement of a more hyper-
polarized Va. Fig. 7 directly shows that removal of
inactivation through mutation has no effect on channel
activation voltage, and thus the unmasking of a rate-limiting
(or at least slow) activation after the removal of inactivation
cannot account for the 20-mV shift in hH1 Va.
A structural difference between rSkM1 and hH1
that is linked somehow to the III-IV linker may
explain the observed functional diversity
While the neuroblastoma model describes sodium channel
activity in neuroblastoma cell lines, the data presented here
indicate directly that the 12–20-mV shift in hH1 Va mea-
sured after antibody and papain treatment cannot be ex-
plained by this model. Papain and antibody treatments sim-
ilarly remove inactivation from rSkM1 and from hH1.
However, a second phenomenon, a shift in hH1 Va while
rSkM1 Va remains nearly constant, appears to be indepen-
dent of the removal of inactivation. As shown in Fig. 7,
activation voltage for the inactivation-deficient mutant,
hH1Q3, is nearly identical to hH1 Va both before and after
papain treatment, with hH1 and hH1Q3 shifting by20 mV
in the hyperpolarized direction after papain treatment.
These data indicate that the shift in hH1 Va is not due to the
uncoupling of inactivation from activation, but that papain
(1Ab) has a second, independent effect on hH1 that is not
observed for papain (1Ab)-treated rSkM1.
Thus the data suggest that there is a functionally impor-
tant cytoplasmic (or a structure that is linked to cytoplasmic
regions) structural difference between rSkM1 and hH1. This
structure somehow alters the voltage dependence of hH1
activation, but not rSkM1 activation, and is apparently
localized either to the III-IV linker or to an area interacting
with this region (see Fig. 8). Papain and 1Ab treatment
alter the impact this structure has on channel function,
causing a measured shift in hH1 Va.
These data are the first to describe a phenomenon in
which channel cytoplasmic regions impact the voltage de-
pendence of cardiac channel activation. While several stud-
ies have implicated S4 segments involved in the inactivation
mechanism of the channel (Chen et al., 1996; Ji et al., 1996;
Cha et al., 1999), cytoplasmic effects on cardiac channel
activation mechanisms have not been described.
Through the parallel functional comparison of two so-
dium channel isoforms, a significant difference in channel
function was observed. The data are consistent with a cy-
toplasmic structure within, near, or interacting with the
III-IV linker of hH1 that alters the voltage dependence of
channel activation. This structure helps to set hH1 activa-
tion voltage to more depolarized potentials. Disrupting or
interacting with this region allows the channel to activate at
lesser depolarizations and thus causes a shift in hH1 Va.
There cannot be complete overlap of this region and the
consensus inactivation sequence (IFM), given the data
showing that hH1Q3 Va and wild-type hH1 Va are affected
similarly by papain. Moreover, given the similarities be-
tween hH1 and rSkM1 III-IV linker regions (only seven of
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the 53 amino acids making up the III-IV linker regions
differ between the two isoforms), other regions with which
the III-IV linker is involved may be responsible for the
observed shift in hH1 Va. Because rSkM1 Va did not shift
after papain or 1Ab treatment, rSkM1 is either missing this
region, or this region is differently linked (if at all) to
channel activation. Comparative studies of structural differ-
ences between hH1 and rSkM1 within, near, or involved
with the III-IV linker would be informative and are neces-
sary to gain insight into the specific region(s) responsible
for this phenomenon.
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